Your browser doesn't support javascript.
loading
Acute respiratory failure in immunocompromised patients: outcome and clinical features according to neutropenia status.
Mokart, Djamel; Darmon, Michael; Schellongowski, Peter; Pickkers, Peter; Soares, Marcio; Rello, Jordi; Bauer, Philippe R; van de Louw, Andry; Lemiale, Virginie; Taccone, Fabio Silvio; Martin-Loeches, Ignacio; Salluh, Jorge; Rusinova, Katerina; Mehta, Sangeeta; Antonelli, Massimo; Kouatchet, Achille; Barratt-Due, Andreas; Valkonen, Miia; Landburg, Precious Pearl; Bukan, Ramin Brandt; Pène, Frédéric; Metaxa, Victoria; Burghi, Gaston; Saillard, Colombe; Nielsen, Lene B; Canet, Emmanuel; Bisbal, Magali; Azoulay, Elie.
Afiliación
  • Mokart D; Réanimation Polyvalente Et Département D'Anesthésie Et de Réanimation, Institut Paoli-Calmettes, 232 Bd Sainte Marguerite 13009, Marseille Cedex 09, France. mokartd@ipc.unicancer.fr.
  • Darmon M; Medical Intensive Care Unit, APHP, Hôpital Saint­Louis, Famirea Study Group, ECSTRA Team and Clinical Epidemiology, UMR 1153, Center of Epidemiology and Biostatistics, Sorbonne Paris Cité, CRESS, INSERM, Paris Diderot Sorbonne University, Paris, France.
  • Schellongowski P; Department of Medicine I, Medical University of Vienna, Vienna, Austria.
  • Pickkers P; The Department of Intensive Care Medicine (710), Radboud University Medical Center, Nijmegen, The Netherlands.
  • Soares M; The Department of Critical Care and Graduate Program in Translational Medicine, D'Or Institute for Research and Education, Programa de Pós-Graduação Em Clínica Médica, Rio de Janeiro, Brazil.
  • Rello J; CIBERES, Instituto de Salud Carlos III, Barcelona, Spain.
  • Bauer PR; Clinical Research/Epidemiology In Pneumonia and Sepsis (CRIPS), Vall d'Hebron Institute of Research (VHIR), Barcelona, Spain.
  • van de Louw A; Anesthesiology Department, Clinical Research in ICU, CHU Nîmes, University Montpellier, Nîmes, France.
  • Lemiale V; Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.
  • Taccone FS; Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA, USA.
  • Martin-Loeches I; Medical Intensive Care Unit, APHP, Hôpital Saint­Louis, Famirea Study Group, ECSTRA Team and Clinical Epidemiology, UMR 1153, Center of Epidemiology and Biostatistics, Sorbonne Paris Cité, CRESS, INSERM, Paris Diderot Sorbonne University, Paris, France.
  • Salluh J; Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Rusinova K; Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St. James's Hospital, Dublin, Ireland.
  • Mehta S; Department of Clinical Medicine, Trinity College, Wellcome Trust­HRB Clinical Research Facility, St James Hospital, Dublin, Ireland.
  • Antonelli M; The Department of Critical Care and Graduate Program in Translational Medicine, D'Or Institute for Research and Education, Programa de Pós-Graduação Em Clínica Médica, Rio de Janeiro, Brazil.
  • Kouatchet A; Department of Anesthesiology and Intensive Care Medicine and Institute for Medical Humanities, 1St Faculty of Medicine, Charles University in Prague and General University Hospital, Prague, Czech Republic.
  • Barratt-Due A; Department of Medicine and Interdepartmental Division of Critical Care Medicine, Sinai Health System, University of Toronto, Toronto, ON, Canada.
  • Valkonen M; Dept of Anesthesia Intensive Care and Emergency Medicine, Fondazione Policlicnico Universitario A.Gemelli IRCCS. Università Cattolica del Sacro Cuore, Rome, Italy.
  • Landburg PP; Department of Medical Intensive Care Medicine, University Hospital of Angers, Angers, France.
  • Bukan RB; Department of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.
  • Pène F; Division of Intensive Care Medicine, Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Metaxa V; Department of Critical Care, University Medical Center Groningen, Groningen, The Netherlands.
  • Burghi G; Department of Anesthesiology I, Herlev University Hospital, Herlev, Denmark.
  • Saillard C; Medical ICU, Cochin Hospital, Assistance Publique-Hôpitaux de Paris and University Paris Descartes, Paris, France.
  • Nielsen LB; King's College Hospital, London, SE5 9RS, UK.
  • Canet E; Terapia Intensiva, Hospital Maciel, Montevideo, Uruguay.
  • Bisbal M; Réanimation Polyvalente Et Département D'Anesthésie Et de Réanimation, Institut Paoli-Calmettes, 232 Bd Sainte Marguerite 13009, Marseille Cedex 09, France.
  • Azoulay E; Intensive Care Department, University of Southern Denmark, Odense, Denmark.
Ann Intensive Care ; 10(1): 146, 2020 Oct 22.
Article en En | MEDLINE | ID: mdl-33090310
ABSTRACT

BACKGROUND:

The impact of neutropenia in critically ill immunocompromised patients admitted in a context of acute respiratory failure (ARF) remains uncertain. The primary objective was to assess the prognostic impact of neutropenia on outcomes of these patients. Secondary objective was to assess etiology of ARF according to neutropenia.

METHODS:

We performed a post hoc analysis of a prospective multicenter multinational study from 23 ICUs belonging to the Nine-I network. Between November 2015 and July 2016, all adult immunocompromised patients with ARF admitted to the ICU were included in the study. Adjusted analyses included (1) a hierarchical model with center as random effect; (2) propensity score (PS) matched cohort; and (3) adjusted analysis in the matched cohort.

RESULTS:

Overall, 1481 patients were included in this study of which 165 had neutropenia at ICU admission (11%). ARF etiologies distribution was significantly different between neutropenic and non-neutropenic patients, main etiologies being bacterial pneumonia (48% vs 27% in neutropenic and non-neutropenic patients, respectively). Initial oxygenation strategy was standard supplemental oxygen in 755 patients (51%), high-flow nasal oxygen in 165 (11%), non-invasive ventilation in 202 (14%) and invasive mechanical ventilation in 359 (24%). Before adjustment, hospital mortality was significantly higher in neutropenic patients (54% vs 42%; p = 0.006). After adjustment for confounder and center effect, neutropenia was no longer associated with outcome (OR 1.40, 95% CI 0.93-2.11). Similar results were observed after matching (52% vs 46%, respectively; p = 0.35) and after adjustment in the matched cohort (OR 1.04; 95% CI 0.63-1.72).

CONCLUSION:

Neutropenia at ICU admission is not associated with hospital mortality in this cohort of critically ill immunocompromised patients admitted for ARF. In neutropenic patients, main ARF etiologies are bacterial and fungal infections.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Ann Intensive Care Año: 2020 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Ann Intensive Care Año: 2020 Tipo del documento: Article País de afiliación: Francia
...